Clinical Trial Update: Eltrombopag Olamine in Improving Platelet Recovery in Older Patients With Acute Myeloid Leukemia Undergoing Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating eltrombopag olamine to improve platelet recovery in older patients with acute myeloid leukemia undergoing chemotherapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Eltrombopag Olamine (eltrombopag olamine)

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Basophilic Leukemia | Phase 2 | Status: UNKNOWN | Results posted: 2020-11-24